NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
THE OPERATING SYSTEM FOR PERSONALIZED THERAPEUTICS
ST13
US500000099145508Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Filing basis
First use anywhere
First use in commerce
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Holders
Representatives
David S Kerr Berg Hill Greenleaf Ruscitti LLP
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Software as a service (SAAS) services featuring software for generating, curating, and summarizing patient-specific target and variant intelligence for personalized therapy design, and automating literature review and report generation for patient cases in the field of drug development, custom drug development, and personalized anti-sense RNA drug development; Software as a service (SAAS) services featuring software for using artificial intelligence (AI) for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for managing laboratory workflows and inventory, and managing patient intake and case files in the field of drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for electronic storage, version control, and indexing of protocols, results, and case documentation and analytics in the field of drug development, custom drug development, and personalized anti-sense RNA drug development, all of the foregoing using artificial intelligence (AI)
History of USPTO decisions and trademark events.
17 publications found
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
REGISTERED-SUPPLEMENTAL REGISTER
01/27/2026
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/02/2026
USE AMENDMENT ACCEPTED
01/02/2026
TEAS/EMAIL CORRESPONDENCE ENTERED
01/02/2026
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2025
AMENDMENT TO USE PROCESSING COMPLETE
12/18/2025
USE AMENDMENT FILED
12/18/2025
TEAS AMENDMENT OF USE RECEIVED
12/18/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2025
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/22/2025
NON-FINAL ACTION E-MAILED
09/22/2025
NON-FINAL ACTION WRITTEN
09/22/2025
ASSIGNED TO EXAMINER
09/12/2025
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/27/2025
APPLICATION FILING RECEIPT MAILED
04/19/2025
NEW APPLICATION ENTERED
04/19/2025
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.